Metraipolis › archive › dc_3584f1a456be

Sintilimab plus cisplatin and nab-paclitaxel induction treatment for locally advanced borderline-resectable oesophageal squamous cell carcinoma: A single-arm,… — Europe PMC PMID:42112766

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42112766
DOI
10.1002/ctm2.70691
License (as archived)
solo-consultazione
Archived
2026-11-02T19:55:26.522Z
SHA-256 of the archived text
c89333c71e15a53aaf3461f7439cb2ef0e6fab157b325633e2ea1b27b3bee789
Stable URL of this page
https://metraipolis.com/documento/dc_3584f1a456be

How to cite

Sintilimab plus cisplatin and nab-paclitaxel induction treatment for locally advanced borderline-resectable oesophageal squamous cell carcinoma: A single-arm,… — Europe PMC PMID:42112766 — Europe PMC (en), https://europepmc.org/article/MED/42112766 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3584f1a456be (Metraipolis archive dc_3584f1a456be, sha256 c89333c71e15a53aaf3461f7439cb2ef0e6fab157b325633e2ea1b27b3bee789)
BibTeX
@misc{dc3584f1a456be,
  title = {Sintilimab plus cisplatin and nab-paclitaxel induction treatment for locally advanced borderline-resectable oesophageal squamous cell carcinoma: A single-arm,… — Europe PMC PMID:42112766},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42112766},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3584f1a456be; sha256 c89333c71e15a53aaf3461f7439cb2ef0e6fab157b325633e2ea1b27b3bee789},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42112766. Agents can read the archived copy with the MCP tool read_document.